Clinical trials: Menstruation Disturbances

Endometriosis

A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain

• Completed
• Age: 18 to 49 years
• Phase 3
• Results posted

A randomized study evaluating the safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.

Trial name

ELARIS EM-II (NCT01931670)

Testing

Elagolix

Volunteers

815 people

Sponsor

AbbVie